TNF and inflammatory bowel disease: In this pilot study, we aimed to compare a small cohort of SARS-CoV-2 mRNA-vaccinated IBD patients under anti-TNF therapy with healthy individuals without previous SARS-CoV-2 infection regarding their functional antibody responses to several viral variants.